Experimental AI designed medication shows potential in anti aging trial

In a 12 week clinical study involving 42 participants, a drug developed by Insilico Medicine demonstrated reductions in measured biological age across six testing metrics. Originally created for lung disease, the therapeutic compound requires extensive additional trials because biological age measurements are not yet standardized.